Brazilian farmers sue Bayer to reclaim $151 million in royalties on GMO cotton

cotton crop cotton tree plant

Brazilian cotton producers in the state of Mato Grosso on [July 11] sued Bayer AG, seeking to cancel the chemical companyโ€™s patent protection for its Bollgard II RR Flex genetically modified cotton seed, according to a statement sent to Reuters.

The farmers, hoping to regain $151 million in royalty payments, claim the genetically modified seed does not constitute a de facto technological innovation, according to the statement issued by the Mato Grosso Cotton Producers Association (AMPA). The lawsuit also names Brazilโ€™s national patents office as a defendant.

Mato Grosso soybean farmers used a similar argument when they sued in Brazil to cancel patent rights over the widely used Intacta RR2 PRO seed.

Read full, original article: Brazil cotton farmers sue Bayer over patent on GMO seed

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates โ€˜skyrocketingโ€™ as RFK, Jr. and MAHA claims? The evidence says mostly the opposite
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: โ€˜Safer for children?โ€™ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
png-pill-omega-Supp-fish-oil
Millions take omega-3 fish oil for brain health. New research suggests it may do the opposite.
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT Image May 14, 2026, 09_51_35 PM
Facebook swamped by hundreds of thousands of scam ads for illegal or dangerous medical products
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformationย 
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-May-13-2026-12_43_37-PM-2
Longevity: Is cellular rejuvenation even possible?
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.